Human haemopoietic maturation factor
    17.
    发明授权
    Human haemopoietic maturation factor 失效
    人类造血成熟因子

    公开(公告)号:US06790826B2

    公开(公告)日:2004-09-14

    申请号:US10004832

    申请日:2001-12-07

    IPC分类号: A61K3816

    CPC分类号: C07K14/475 A61K38/00

    摘要: Disclosed are human haemopoietic maturation factor polypeptides and DNA (RNA) encoding such haemopoietic maturation factor polypeptides. Also provided are procedures for producing such polypeptides by recombinant techniques and for using such polypeptides for treating leukemia, auto-immune diseases and blood related disorders. Antagonists against such polypeptides and their use as a therapeutic to prevent expansion of T-cell populations are also disclosed. Diagnostic assays are also disclosed to detect both the presence of mutations in the haemopoietic maturation factor nucleic acid sequences and altered levels of the protein.

    摘要翻译: 公开了人类造血成熟因子多肽和编码这种造血成熟因子多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法,并且使用这些多肽来治疗白血病,自身免疫疾病和与血液相关的疾病。 还公开了抗这些多肽的拮抗剂及其作为治疗剂用于预防T细胞群扩增的用途。 还公开了诊断测定以检测造血成熟因子核酸序列中突变的存在和蛋白质的改变的水平。

    Antibodies that bind human haemopoietic maturation factor
    18.
    发明授权
    Antibodies that bind human haemopoietic maturation factor 失效
    结合人类造血成熟因子的抗体

    公开(公告)号:US06346246B1

    公开(公告)日:2002-02-12

    申请号:US09333033

    申请日:1999-06-15

    IPC分类号: A61K39395

    CPC分类号: C07K14/475 A61K38/00

    摘要: Disclosed is human haemopoietic maturation factor polypeptides and DNA (RNA) encoding such haemopoietic maturation factor polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and the use of such polypeptides for treating leukemia, auto-immune diseases and blood related disorders. Antagonists against such polypeptides and their use as a therapeutic to prevent expansion of T-cell populations is also disclosed. Diagnostic assays are also disclosed which detect the presence of mutations in the haemopoietic maturation factor nucleic acid sequences and altered levels of the protein.

    摘要翻译: 公开了人类造血成熟因子多肽和编码这种造血成熟因子多肽的DNA(RNA)。 还提供了通过重组技术产生此类多肽的方法以及使用这些多肽来治疗白血病,自身免疫疾病和血液相关病症。 还公开了抗这些多肽的拮抗剂及其作为预防T细胞群扩增的治疗剂的用途。 还公开了诊断测定法,其检测造血成熟因子核酸序列中突变的存在和蛋白质的改变水平。